SS Innovations International opened higher at $1.53, compared with its previous close of $1.51. In the last trading session, the stock traded between $1.32 and $1.53. It showed a downward intraday trend.
An investment of $100 made 4 years ago in SS Innovations International is now worth
$ 16.25
Resulting in a loss of
$ 83.75 (83.75%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
$-0.19 (-12.85%)
Day High
$1.53
Day Low
$1.32
Day Open
$1.53
Prev Close
$1.51
Volume
1,53,729
1W Return
-42.23%
1M Return
-48.65%
3M Return
-64.77%
6M Return
-67.75%
1Y Return
-80.47%
Market Cap ($ Mn)
264
PE Ratio
-
PB Ratio
13.04
PEG Ratio
-
ROE
-34.87%
ROCE
-18.95%
EPS (TTM)
$-0.01
1 Week
-42.23%
1 Month
-48.65%
3 Months
-64.77%
6 Months
-67.75%
9 Months
-60.36%
SS Innovations International CFO Sarah Romano steps down on August 21
Sarah Romano steps down as CFO of SS Innovations International. Departure effective August 21, 2026. Company states no disagreements on financial reporting or controls.
2mo agoSS Innovations Q2 Results: EPS beats estimate, sales up 39% YoY
SS Innovations delivered better-than-expected Q2 results with an EPS of $(0.01), beating the $(0.02) estimate. Revenue climbed 39.4% YoY to $13.94 million, significantly exceeding the $11 million forecast. The results indicate improved operational efficiency alongside robust top-line growth.
3mo agoSS Innovations to showcase SSi Mantra at SRS 2026
SS Innovations International, Inc. is set to showcase its SSi Mantra surgical robotic system at SRS 2026 in Florida, featuring a live kidney telesurgery from India. The company reports 12,375 cumulative procedures performed with the system as of July 6, 2026. CEO Dr. Sudhir Srivastava will lead multiple sessions highlighting the technology's global accessibility.
3mo agoSS Innovations appoints Sarah M. Romano as CFO effective August 3
SS Innovations International, Inc. has named Sarah M. Romano as its new Chief Financial Officer, effective August 3, 2026. Romano, a veteran in medical technology finance, will oversee financial operations as the company targets U.S. FDA approval for its SSi Mantra system. Her appointment underscores SS Innovations' focus on scaling its global footprint and capitalizing on growth opportunities in the surgical robotics market.
4mo agoSS Innovations wins Outstanding Company at 2026 Surgical Robotics Industry Awards
SS Innovations International, Inc. won the Outstanding Company award at the 2026 Surgical Robotics Industry Awards. The SSi Mantra system has completed 11,719 procedures, including 612 cardiac and 175 telesurgeries, across 14 countries as of June 22, 2026.
4mo agoSS Innovations International enters ATM sales agreement with Virtu Americas
SS Innovations International entered into an ATM sales agreement with Virtu Americas to sell up to $50 million in stock, as disclosed in a Sec filing.
4mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $109.29 | -1.06% | $1,89,283.94M | 36.28 | |
| $449.53 | -0.11% | $1,55,826.88M | 42.73 | |
| $101.61 | +0.02% | $1,29,976.46M | 24.46 | |
| $318.79 | -1.70% | $1,21,360.48M | 34.27 | |
| $45.13 | +0.96% | $65,414.72M | 18.96 | |
| $105.81 | +1.73% | $60,840.75M | 53.70 | |
| $214.52 | +0.90% | $58,432.46M | 44.07 | |
| $82.60 | -1.26% | $37,346.60M | 16.49 | |
| $42.16 | +3.06% | $37,044.18M | 89.05 | |
| $72.46 | -2.16% | $35,027.16M | 54.55 | |
| $237.20 | +1.61% | $33,458.08M | 23.04 | |
| $80.35 | +0.53% | $29,964.75M | 36.04 |
An investment of $100 made 4 years ago in SS Innovations International is now worth
$ 16.25
Resulting in a loss of
$ 83.75 (83.75%)
Note: Past profits do not guarantee future returns.
